Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics Student Roster

Director

Larry M. Karnitz, Ph.D.

Review the focus areas, mentors and publications of current and former trainees in the Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.

Appointee Mentor(s) Research focus Mayo Clinic publications
Elizabeth K. Wiese Taro Hitosugi, Ph.D. The role of SDR9C7 in multiple myeloma Publications on PubMed
Jordan M. Grainger Liewei Wang, M.D., Ph.D. Study of copy number amplification and chemo-response in triple negative breast cancer Publications on PubMed
Erin M. Higgins Michael J. Ackerman, M.D., Ph.D. Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy Publications on PubMed
Rebecca L. Kelly Larry M. Karnitz, Ph.D. Kinetic parameters for the metabolism of endoxifen Publications on PubMed
Drew R. Neavin, Ph.D. Richard Weinshilboum, M.D. Metabolomics and single nucleotide polymorphism analyses to identify genetic components of response to SSRIs Publications on PubMed
Sherri M. Biendarra-Tiegs Timothy J. Nelson, M.D., Ph.D. Patient-derived induced pluripotent stem cells to investigate cardiac drug toxicities Publications on PubMed
Christopher Livia Atta Behfar, M.D., Ph.D. Mechanisms of reperfusion injury after myocardial ischemia and regenerative therapies to treat ischemia Publications on PubMed
Katherine Minter Dykhouse Timothy J. Nelson, M.D., Ph.D. Modeling terminal differentiation of cardiomyocytes using the directed differentiation of human induced pluripotent stem cells to cardiomyocytes Publications on PubMed
Stephanie L. Safgren, Ph.D., M.S. Martin E. Fernandez-Zapico, M.D. The chromatin remodeler SMARCA2 cooperates with GLI1 to regulate gene expression in pancreatic cancer cells Publications on PubMed
Cordelia D. McGehee

Scott H. Kaufmann, M.D., Ph.D.

Hu Li, Ph.D.

 Identification of mechanisms of treatment resistance and responsiveness in ovarian cancer using systems pharmacology Publications on PubMed
Carl T. Gustafson Michael J. Yaszemski, M.D., Ph.D. Wnt targets and therapeutic approaches in osteosarcoma Publications on PubMed
Jamie D. Kapplinger, M.D., Ph.D. Michael J. Ackerman, M.D., Ph.D. Enhanced classification of non-synonymous single nucleotide variants in the SCN5A-encoded Nav1.5 cardiac sodium channel Publications on PubMed
Alfreda D. Nelson Diana Gil Pages, Ph.D. Anti-TCR-CD3 fab homodimerization and the effects of ligand bivalency on T cell activation Publications on PubMed

Review career outcomes for alumni of the T32 Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics (MPET) at Mayo Clinic:

Current career Former MPET T32 Ph.D. and M.D.-Ph.D. trainees*
Research — academic faculty 42%
Research — academic staff 17%
Research — industry 17%
Research — government 8%
Teaching — faculty 8%
Medical practice 0%
Other industry or medical career 8%
*Trainees supported by the National Institute of General Medical Sciences-funded Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics (MPET) for the last 15 years.